Clinical Trials Browser

Phase 2 × OTHER × EGFR tyrosine kinase inhibitor 324674 × Clear all

NCT01998061 2013-12-20

Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung